EconomyEditor's PickNewsOrbimed Capital increased stake in Arcutis Biotherapeutics, Inc.

1 year ago113 min
imageStock Markets54 minutes ago (Oct 06, 2020 06:30PM ET)

(C) Reuters. Orbimed Capital increased stake in Arcutis Biotherapeutics, Inc.

On the 2nd of October, Orbimed Capital bought 496 thousand Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) shares for $12 million at an average price of $25.00 per share.
Shares of Arcutis Biotherapeutics, Inc. are up 1.46% since the transaction.

Orbimed Capital’s holding in Arcutis Biotherapeutics, Inc. increased to about 902 thousand shares with the purchase.

Orbimed Capital increased stake in Arcutis Biotherapeutics, Inc.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Leave a Reply

Your email address will not be published. Required fields are marked *